Liaoning He Eye Hospital Co., Ltd. (301103)
XSHE XSHE Primary Summary
301103 Chart
People also search for
Liaoning He Eye Hospital Co., Ltd. (301103) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Liaoning He Eye Hospital Co., Ltd. ever had a stock split?
Liaoning He Eye Hospital Co., Ltd. Profile
| Health Care Providers & Services Industry | Healthcare Sector | Mr. Wei He CEO | XSHE Exchange | CNE100005899 ISIN |
| China Country | 3,274 Employees | 29 May 2026 Last Dividend | 1 Jun 2022 Last Split | - IPO Date |
Overview
Liaoning He Eye Hospital Group Co., LTD., established in 1995, is a medical institution headquartered in Shenyang, China, dedicated to offering a wide range of eye care services. The company specializes in treating various eye conditions for both children and elderly patients, utilizing advanced medical practices and equipment. With a focus on comprehensive eye health, Liaoning He Eye Hospital Group aims to provide exceptional optometry and ophthalmologic services to improve patients' vision and quality of life.
Products and Services
- Ophthalmopathy in Children and Elderly:
This service focuses on diagnosing and treating eye diseases common in both children and the elderly. The hospital employs specialized pediatric and geriatric ophthalmologists to address the unique eye care needs of these age groups.
- Refraction Services:
Liaoning He Eye Hospital Group offers comprehensive refraction services to diagnose and correct refractive errors such as myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia. These services include eye exams, vision testing, and prescription of corrective lenses or eyeglasses.
- Ocular Surface Services:
The hospital provides treatments and procedures aimed at addressing conditions affecting the ocular surface, including dry eye syndrome, conjunctivitis, and corneal diseases. These services utilize modern diagnostic and therapeutic approaches to restore and maintain the health of the eye's surface.
